MMManiza Muni

Maniza Muni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maniza Muni has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Abu Asad Chowdhury

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh

    2 shared publications
  • Al Amin Sikder

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh

    2 shared publications
  • Fahima Aktar

    Molecular Pharmacology and Herbal Drug Research Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh

    2 shared publications
  • Jakir Ahmed Chowdhury

    Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh

    2 shared publications
  • Shah Amran

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh

    2 shared publications
  • Shaila Kabir

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh

    2 shared publications

Latest Publications

  • Open Access

    Exploration of Antidiabetic Activity of the Whole Plant Extract of Eclipta prostrata by In Silico, In Vitro, and In Vivo Methods

    by Maniza Muni, Mst. Morsheda Akter Mim, Fahima Aktar, Syeda Sadia Afrin, Safaet Alam, Al Amin Sikder, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Shaila Kabir, Zakir Sultan, et al.

    Background: Diabetes is the most common chronic disease worldwide, requiring lifelong medication support. As conventional medications have numerous long-term side effects, herbal drugs, which offer similar effectiveness but fewer complications, are considered an alternative. A common tropical herb, Eclipta prostrata, was tested for its antidiabetic activities. Objectives: The principal objective of this study was to investigate the antidiabetic efficacy of E. prostrata extract using in silico, in vitro, and in vivo methods. Methods: The in silico study comprised ligand library preparation through a literature review, structure optimization using Avogadro software and molecular docking against five antidiabetic macromolecules using PyRx. The in vitro alpha-amylase inhibitory study was conducted using the dried extract of E. prostrata. The in vivo study was performed on alloxan monohydrate-induced diabetic rats at a dose of 150 mg/kg, followed by treatment with three doses of 70% ethanolic extract of the whole plant (250 mg/kg, 500 mg/kg, and 750 mg/kg) for 28 days. Then, plasma glucose levels, plasma glucagon-like peptide-1 (GLP-1) levels, and histopathological assays of rat livers were carried out. Results: The in silico studies helped screen out the most effective antidiabetic constituents of E. prostrata, which may serve as lead compounds for developing antidiabetic drugs in the future. The IC50 value for E. prostrata extract was 22.21 mg/mL in the alpha-amylase assay. The plant extract significantly improved the health of the diabetes-induced rats. Conclusion: Based on these findings, E. prostrata could be an effective natural antidiabetic drug.

  • Open Access

    Exploration of the GLUT-4 Modulation Potential of Gynura procumbens as a Mechanism Behind its Antidiabetic Activity

    by Juhaer Anjum, Maniza Muni, Nusrat Jahan Shawon, Fahima Aktar, Mehadi Hasan, Mohammad Sofi, Rafat Tahsin, Reaz Uddin, Abu Asad Chowdhury, Jakir Ahmed Chowdhury, et al.

    The search for antidiabetic drugs from natural sources has been carried out since diabetes has become a prevalent chronic disease, whose conventional therapy causes several complications in long-term use. Gynura procumbens (GP), a well-known herb for its various activities, has shown promising results against diabetes in several studies. To find whether the mechanism of activity behind this antidiabetic effect is underpinned by the upregulation of a particular glucose transporter (GLUT-4), this experiment was conducted. The GLUT-4 expression levels in Alloxan-induced diabetic rats were compared with untreated healthy rats and rats treated with different doses of G. procumbens extract using enzyme-linked immunosorbent assay (ELISA) specified for rat GLUT-4. All four test groups including the metformin control group showed elevated expression of GLUT-4 in the liver tissue compared to the diabetic control group (p < 0.05, one-way ANOVA). The serum-glucose modulatory antidiabetic activity of ethanolic extract of G. procumbens was therefore mediated though the upregulation of GLUT-4 expression, and consequent increased uptake of glucose.